Chemoinformaics analysis of GANOLUCIDIC-ACID-E
| Molecular Weight | 484.677 | nRot | 5 |
| Heavy Atom Molecular Weight | 440.325 | nRig | 24 |
| Exact Molecular Weight | 484.319 | nRing | 4 |
| Solubility: LogS | -4.746 | nHRing | 0 |
| Solubility: LogP | 4.217 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 83.4489 |
| nHD | 2 | BPOL | 46.7451 |
| QED | 0.474 |
| Synth | 4.912 |
| Natural Product Likeliness | 3.416 |
| NR-PPAR-gamma | 0.777 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.646 |
| Pgp-sub | 0.001 |
| HIA | 0.044 |
| CACO-2 | -5.266 |
| MDCK | 0.0000188 |
| BBB | 0.524 |
| PPB | 0.909892 |
| VDSS | 0.525 |
| FU | 0.0522191 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.785 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.895 |
| CYP2c9-inh | 0.235 |
| CYP2c9-sub | 0.889 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.271 |
| CYP3a4-inh | 0.174 |
| CYP3a4-sub | 0.33 |
| CL | 10.325 |
| T12 | 0.275 |
| hERG | 0.017 |
| Ames | 0.013 |
| ROA | 0.074 |
| SkinSen | 0.034 |
| Carcinogencity | 0.132 |
| EI | 0.01 |
| Respiratory | 0.94 |
| NR-Aromatase | 0.677 |
| Antiviral | Yes |
| Prediction | 0.723813 |